lina

TMN - us stocks

Regeneron Pharmaceuticals Reported Strong Q4 Earnings

On Friday, Regeneron Pharmaceuticals reported a better-than-expected Q4 as sales for their new disease-treating drug, Dupixent, rose. Its stock price increased by 4.25% to $783.13 per share. Also, it is anticipated to hike by 0.07% to $783.31 apiece in the upcoming session. The earnings per share of Regeneron improved to $12.56, above analysts’ expectations of …

Regeneron Pharmaceuticals Reported Strong Q4 Earnings Read More »

Broker News

Compagnie FT Ends Q4-2022 with 8.9% Revenue Rise.

During the Q4 of 2022, Compagnie Financière Tradition (CFT) experienced a steady rise in revenue. The Swiss interdealer broker and operator of a Japanese retail broking giant reported consolidated earnings at CHF 231.1 million.  It was an 8.9% increase from the previous year’s figure after being adjusted for currency fluctuations. The rise is remarkable progress …

Compagnie FT Ends Q4-2022 with 8.9% Revenue Rise. Read More »

Broker News

Devexperts Enhances DXtrade with AI-Chatbot Devexa

Devexperts has announced a new enhancement to its technology offerings for brokers. It has integrated its FX and CFD trading platform, DXtrade, with its AI-powered chatbot for support and sales desks, Devexa.  The integration enables brokers to utilize the chat widget in the web trading terminal to provide instant assistance to traders. In addition, it …

Devexperts Enhances DXtrade with AI-Chatbot Devexa Read More »